CERTIFICATION DETAIL

This EHR Module is 2015 Edition compliant and has been certified by SLI Compliance in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

1. Vendor name: SpectraMedix
2. Date certified: March 9, 2023
3. Product name: VBP Performance Suite
4. Version: 11
5. Certification Edition: 2015 Edition
6. CHPL Product ID: 15.07.05.2359.SPEC.01.00.1.230309
7. Certification criteria:
   

170.315(b)(10) Electronic Health Information export

• QRDA1 format for single patient export and patient population export (Format- https://ecqi.healthit.gov/sites/default/files/2024-CMS-QRDA-I-v1.1-Support-Files.zip)

170.315(c) Clinical Quality Measures

• 315(c)(1) CQM – record and export
• 315(c)(2) CQM – import and calculate
• 315(c)(3) _C CQM – report
• 315(c)(4) CQM – filter

170.315(d) Privacy and Security

• 315(d)(1) Authentication, access control, and authorization
• 315(d)(2) _C Auditable events and tamper-resistance
• 315(d)(3) _C Audit reports
• 315(d)(5) Automatic access time-out
• 315(d)(12) _C Encrypt authentication credentials
• 315(d)(13) _C Multi-factor authentication - VBP Performance Suite provides ‘Two-factor authentication’ which authenticate users using two factors:
  o    Password
  o    One-time passcode (OTP)-one-time code generated by app (using Free OTP app downloaded on user mobile phone)
  (2FA) is a security process in which users provide two different authentication factors to verify themselves.
  

170.315(g) Design and Performance

• 315(g)(4) Quality Management System
• 315(g)(5) Accessibility-centred design

Clinical Quality Measures Successfully Tested:

• CMS002/NQF0418*: Screening for Depression and Follow-Up Plan
• CMS069/NQF0421*: Body Mass Index (BMI) Screening and Follow-Up Plan
• CMS122/NQF0059: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
• CMS124/NQF0032: Cervical Cancer Screening
• CMS125/NQF0031: Breast Cancer Screening
• CMS130/NQF0034: Colorectal Cancer Screening
• CMS131/NQF0055: Diabetes: Eye Exam
• CMS133/NQF0565: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
• CMS134/NQF0062: Diabetes: Medical Attention for Nephropathy
• CMS138/NQF0028*: Tobacco Use: Screening and Cessation Intervention
• CMS139/NQF0101: Falls: Screening for Future Fall Risk
• CMS147/NQF0041: Preventive Care and Screening: Influenza Immunization
• CMS159/NQF0710: Depression Remission at Twelve Months
• CMS165/NQF0018*: Controlling High Blood Pressure
• CMS347/TBD: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
• CMS9/ NQF 480e: Exclusive Breast Milk Feeding
• CMS506: Safe Use of Opioids - Concurrent Prescribing
• CMS71/ NQF 0436: Anticoagulation Therapy for Atrial Fibrillation/Flutter
• CMS72/ NQF 0438: Antithrombotic Therapy By End of Hospital Day 2
• CMS104/ NQF 0435: Discharged on Antithrombotic Therapy
• CMS105/ NQF 0439: Discharged on Statin Medication
• CMS108/ NQF 037: Venous Thromboembolism Prophylaxis
• CMS111/NQF 0497: Median Admit Decision Time to ED Departure Time for Admitted Patients
• CMS190/ NQF 0372: Intensive Care Unit Venous Thromboembolism Prophylaxis
• CMS529/ NQF2879e: Hybrid Hospital-Wide Readmission (HWR)

1.  Additional Software:  SQL Server 2017 Enterprise Edition 
2. Costs Disclosure: “There are no additional types of costs that a user may encounter in the course of implementing and using this Health IT Module's capabilities, whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT's certification.”